Dr. Bhadelia says news of anti-viral Covid drug is 'promising'
Share this -
Infectious diseases physician, Dr. Nahid Bhadelia, reacts to Merck's announcement that its new anti-viral pill reduced deaths and hospitalizations in those infected with Covid-19, and that it plans to file for emergency use authorization. She discusses the politicization of the treatment and vaccinations with Chris Jansing.Oct. 1, 2021